V012-0530 Screening compound: N-({2-[(3,5-dimethylphenoxy)methyl]-1,3-thiazol-4-yl}methyl)-4-methoxy-N-(3-methoxypropyl)benzene-1-sulfonamide

V012-0530 Screening compound: N-({2-[(3,5-dimethylphenoxy)methyl]-1,3-thiazol-4-yl}methyl)-4-methoxy-N-(3-methoxypropyl)benzene-1-sulfonamide
V012-0530 Screening compound: N-({2-[(3,5-dimethylphenoxy)methyl]-1,3-thiazol-4-yl}methyl)-4-methoxy-N-(3-methoxypropyl)benzene-1-sulfonamide alternative view

Chemical Structure Depiction of ChemDiv screening compound V012-0530
N-({2-[(3,5-dimethylphenoxy)methyl]-1,3-thiazol-4-yl}methyl)-4-methoxy-N-(3-methoxypropyl)benzene-1-sulfonamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V012-0530

Molecular Formula

C24H30N2O5S2 (C24 H30 N2 O5 S2)

Compound Name

N-({2-[(3,5-dimethylphenoxy)methyl]-1,3-thiazol-4-yl}methyl)-4-methoxy-N-(3-methoxypropyl)benzene-1-sulfonamide

IUPAC name

N-({2-[(35-dimethylphenoxy)methyl]-13-thiazol-4-yl}methyl)-4-methoxy-N-(3-methoxypropyl)benzene-1-sulfonamide

SMILES

Cc1cc(OCc2nc(CN(CCCOC)S(c(cc3)ccc3OC)(=O)=O)cs2)cc(C)c1

InChI

InChI=1S/C24H30N2O5S2/c1-18-12-19(2)14-22(13-18)31-16-24-25-20(17-32-24)15-26(10-5-11-29-3)33(27,28)23-8-6-21(30-4)7-9-23/h6-9,12-14,17H,5,10-11,15-16H2,1-4H3

InChI Key

OIUBXXKLVFHAPY-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD19864661

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

490.64

Hydrogen Bond Acceptors Count

9.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

12.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

5.012

Distribution Coefficient, logD

5.012

Water Solubility, LogSw

-4.74

Polar Surface Area

65.702

Acid Dissociation Constant (pKa)

27.38

Base Dissociation Constant (pKb)

1.07

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

37.50

V012-0530 in Drug Discovery

Included in Screening Libraries

MCL1 Targeted Library (12200 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic

References: we are preparing a list of scientific research reports with V012-0530 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V012-0530?
Check Price and Availability of V012-0530, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V012-0530 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V012-0530
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V012-0530
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V012-0530 available by request